A rapid increase in respiratory infections and continued spread of the A/H1N1 virus contributed to a sharp rise in retail pharmacy sales in November (particularly as regards sales of non-prescription medicines, which surged by nearly 35% y-o-y). Pharmacy margins also rose markedly, whereas the value of reimbursement dropped slightly over this period.